Conduct disorder (CD) is the leading global cause of mental health burden in children and adolescents and has recently been hypothesized to be a neurodevelopmental disorder. Although prior research has identified neuroanatomical differences associated with CD, it remains unclear whether these differences reflect atypical brain development. Here, we investigated the difference between an individual's brain age and chronological age as a proxy for variations in brain maturation. Using a pretrained model, we estimated brain age from structural neuroimaging data obtained from 1,119 youth with CD and 1,183 typically developing controls across 14 international cohorts participating in the ENIGMA-Antisocial Behavior Working Group. Youth with CD exhibited a statistically robust but small acceleration in brain age compared to typically developing youth (around 0.50 years), which was restricted to the adolescence-onset subtype of the disorder. Our large-scale, coordinated analysis provides the first evidence of accelerated neurodevelopment as a potential mechanism underlying CD.
Uvod: Telezdravstvene storitve so se v medicini močno razširile zlasti med pandemijo covida-19. Namen pregleda literature je bil raziskati dosedanje ugotovitve o telezdravstvu in njegovo uporabo na področju duševnega zdravja. Metode: Uporabljen je bil integrativni pregled literature. V analizo so bili vključeni znanstveni članki, objavljeni med letoma 2010 in 2025, v bazah Medline, PubMed, CINAHL, Google Scholar in Elsevier. Uporabljeni so bili iskalni nizi v slovenskem in angleškem jeziku. Potek iskanja je prikazan v diagramu PRISMA. Za obdelavo podatkov je bila uporabljena deskriptivna vsebinska analiza z oblikovanjem tematskih skupin. Članki so bili ovrednoteni po hierarhiji dokazov, metodološka kakovost pa ocenjena z orodjema MMAT in AMSTAR 2. V končno analizo je bilo vključenih petnajst člankov. Rezultati: Na podlagi analize vključenih virov sta bili oblikovani dve vsebinski kategoriji: (1) vloga medicinskih sester pri izvajanju telemedicine v duševnem zdravju in (2) uporabnost telemedicinskih storitev v duševnem zdravju. Rezultati kažejo na izrazito povečanje rabe telezdravstvenih storitev, posebej v času covida-19, hkrati pa opozarjajo na določene pomanjkljivosti. Diskusija in zaključek: Telezdravstvene storitve na področju duševnega zdravja so postale nepogrešljiv del sodobne zdravstvene oskrbe. Medicinske sestre pomembno prispevajo k varni in kakovostni obravnavi pacientov na daljavo. Identificirani so bili izzivi, ki vplivajo na izvajanje telezdravstvenih storitev. Ugotovitve kažejo na potrebo po nadaljnjih raziskavah, usmerjenih v krepitev kompetenc medicinskih sester in izboljšanje digitalne podpore v klinični praksi.
Repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (dlPFC) is an established treatment for treatment-resistant depression (TRD), but its molecular and network-level mechanisms remain incompletely understood, and the two levels have rarely been measured together. We studied eleven patients with TRD (6 female; mean age 47.5 ± 12.5 years) who underwent 20 sessions of 10 Hz left-dlPFC rTMS over 6 weeks, combining two complementary analytic arms in the same patients: a hypothesis-driven arm testing pre-specified changes in source-reconstructed resting-state EEG directed connectivity (Phase Slope Index, PSI) across the default mode (DMN), frontoparietal (FPN), salience (SN) and dorsal attention (DAN) networks, and a discovery arm profiling plasma microRNA (miRNA) expression by next-generation sequencing. Clinically, treatment produced significant improvement on the IDS-30 (p = 0.008), BDI-II (p = 0.005), and the negative-affect and anhedonia subscales of the LAPS. In the connectivity arm, the pre-specified limbic DMN changes were confirmed—directed drive from the posterior cingulate cortex to the subgenual anterior cingulate decreased, and directed drive from the dlPFC to the posterior cingulate increased—and the largest single effect in the dataset was a decrease in directed drive from the left dlPFC to the right superior parietal lobule (p = 0.005), implicating FPN-to-DAN reorganization. In the discovery arm, 14 miRNAs were nominally differentially expressed (p < 0.05, uncorrected; none survived false-discovery-rate correction), dominated by upregulation of the plasticity-associated let-7 and miR-30 families. Linking the arms, the strongest molecular–connectivity correlations (|r| = 0.90–0.93) fell on FPN-to-DAN and SN-to-DMN edges, consistent with normalization of the pathological DMN–DAN anticorrelation in TRD. Together these results provide the first evidence of coupled plasma miRNA and directed multi-network connectivity changes following rTMS in TRD, identifying candidate molecular correlates of a three-component network reorganization. Replication in larger, sham-controlled samples is required.
Background Fatigue is a common symptom of multiple sclerosis (MS) and impacts quality of life, yet the role of chrononutrition and sleep in MS management remains underexplored. We aimed to investigate the cross-sectional associations of meal and sleep timing with fatigue in persons with MS (pwMS).Methods We implemented a chrononutrition questionnaire within the Swiss MS Registry to quantify the relationships between meal timing, sleep patterns and fatigue among pwMS.Results In unadjusted analyses of 958 participants (median age 49 years, 73% women), a longer interval between the first and last meals (eating window) was associated with less fatigue (OR per 1 SD change in predictor=0.84, 95% CI 0.75 to 0.94), while later wake-up (OR 1.26, 95% CI 1.12 to 1.43) and first meal (OR 1.28, 95% CI 1.14 to 1.44) were associated with more fatigue. Later weekend versus weekday patterns (‘social jetlag’) across meal and sleep timing were associated with less fatigue.Adjustment for lifestyle factors attenuated most of the relationships, with employment status being the most influential. After adjustment, a larger ‘social jetlag’ in first meal (OR 0.86, 95% CI 0.76 to 0.97) and going to bed later (OR 0.86, 95% CI 0.76 to 0.97) remained associated with less fatigue, while a longer time in bed (OR 1.28, 95% CI 1.12 to 1.46) remained associated with more fatigue.Conclusions Associations of meal and sleep timing with fatigue in pwMS were influenced by lifestyle factors, particularly employment status. After adjustment, eating the first meal later during weekends compared with weekdays, going to bed later and a shorter time in bed were associated with less reported fatigue. The apparent benefits of ‘social jetlag’ on first meal times require confirmation from prospective and interventional studies.
Introduction Clozapine remains the most effective medication for the treatment of treatment-resistant schizophrenia, as confirmed by numerous studies and extensive clinical experience. Nevertheless, in clinical practice it is often introduced too late or not at all. The main reasons for this include fear of adverse effects, lack of clinical experience, and the more demanding process of initiation and monitoring. Among the most significant potential complications are neutropenia, delayed intestinal motility, myocarditis, sedation, tachycardia, and orthostatic hypotension. However, when properly monitored, clozapine treatment can profoundly enhance quality of life, even in patients who have failed to respond to multiple prior antipsychotic therapies. Objectives - Methods - Results The patient was first hospitalized at the age of 28 due to a psychotic episode. She was treated with risperidone, but residual delusions persisted, and a diagnosis of paranoid schizophrenia was confirmed. After discharge, due to cognitive decline, she was unable to continue her studies. She lived with her parents and took part in rehabilitation programs and community activities organized by a Slovenian non-governmental organization for mental health. At the age of 30, she was hospitalized again due to severe distress related to feelings of aging. Over the following years, she was treated with several antipsychotics, including quetiapine, paliperidone, and amisulpride, but without significant clinical improvement. She spent most of her time at home, rarely leaving the apartment. Her only regular social contact was a volunteer who occasionally accompanied her on walks. She lived in constant fear, interpreting global events such as the COVID-19 pandemic and the wars in Ukraine and Gaza as being personally connected to her. At the age of 50, she was hospitalized once more, and clozapine treatment was initiated. After six months of therapy, her condition improved markedly. She achieved a satisfactory remission and described an inner sense of calm. She began taking daily walks again and became more engaged in everyday life. Her family described her as calm, stable, and more emotionally present. Conclusions Clozapine remains a cornerstone in the treatment of resistant schizophrenia, yet it is still underused due to persistent prejudices and fears. This case demonstrates that introducing clozapine can be justified even in chronic patients where improvement may seem unlikely. New monitoring guidelines, which simplify hematological follow-up—requiring neutrophil count checks every three months after the first year of treatment and only once per year after two years of stability—are expected to reduce clinicians’ reluctance and enable broader use of this remarkably effective medication. Disclosure of Interest None Declared